Use of lipid-lowering agents is not associated with improved outcomes for tuberculosis patients on standard-course therapy: A population-based cohort study
Author:
Funder
the National Health Research Institute
Wan-Fang Hospital
Publisher
Public Library of Science (PLoS)
Subject
Multidisciplinary
Reference15 articles.
1. World Health Organization. Tuberculosis. Available online: http://www.who.int/mediacentre/factsheets/fs104/en/index.html. (accessed on 17 July 2018)
2. New drugs against tuberculosis: problems, progress, and evaluation of agents in clinical development;J van den Boogaard;Antimicrob Agents Chemother,2009
3. Statin, calcium channel blocker and Beta blocker therapy may decrease the incidence of tuberculosis infection in elderly Taiwanese patients with type 2 diabetes;MY Lee;Int J Mol Sci,2015
4. Simvastatin increases the in vivo activity of the first-line tuberculosis regimen;C Skerry;J Antimicrob Chemother,2014
5. Statin therapy reduces the mycobacterium tuberculosis burden in human macrophages and in mice by enhancing autophagy and phagosome maturation;SP Parihar;J Infect Dis,2014
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. An Update to Novel Therapeutic Options for Combating Tuberculosis: Challenges and Future Prospectives;Current Pharmaceutical Biotechnology;2024-10
2. Revolutionizing control strategies against Mycobacterium tuberculosis infection through selected targeting of lipid metabolism;Cellular and Molecular Life Sciences;2023-09-14
3. Cardiovascular Involvement in Tuberculosis: From Pathophysiology to Diagnosis and Complications—A Narrative Review;Diagnostics;2023-01-25
4. Cohort Profile: Korean Tuberculosis and Post-Tuberculosis Cohort Constructed by Linking the Korean National Tuberculosis Surveillance System and National Health Information Database;Journal of Preventive Medicine and Public Health;2022-05-31
5. Magnesium exposure increases hip fracture risks in patients with chronic kidney disease: a population-based nested case–control study;Osteoporosis International;2022-01-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3